Sort
10,829 grants matching “car t”
I4C 2.0: Immunotherapy for Cure
$4,653,643Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2025 · AI
PRE-IND STUDIES OF FIRST-GENERATION DUAL-TARGETED, FINE-TUNED, IMMUNE-RESTORING (DFIR) CAR-T CELL THERAPY TO ACHIEVE CURES OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
$4,650,116Dana-Farber Cancer Institute, Inc. · · FY2021 · Defense Health Agency
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,036Luis J. Montaner · Wistar Institute · UM1 · FY2016 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,036Luis J. Montaner · Wistar Institute · UM1 · FY2019 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,036Luis J. Montaner · Wistar Institute · UM1 · FY2018 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,035Luis J. Montaner · Wistar Institute · UM1 · FY2017 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,035Luis J. Montaner · Wistar Institute · UM1 · FY2020 · AI
Cell and Gene Therapy for HIV Cure
$4,564,019Keith R Jerome · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL USING TRISPECIFIC (CD19/CD20/CD22) CAR T CELLS FOR THE TREATMENT OF RELAPSED/REFRACTORY B CELL LYMPHOMA
$4,523,000University Of Maryland, Baltimore · · FY2025 · Defense Health Agency
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO
$4,461,312David B. Goldstein · Columbia University Health Sciences · UG3 · FY2016 · OD
Adaptive Platform for Personalized Engagement
$4,454,562Praduman Jain · Vignet, Inc. · U24 · FY2020 · OD
I4C 2.0: Immunotherapy for Cure
$4,423,055Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2024 · AI
Stanford Cancer Institute
$4,416,653Steven E Artandi · Stanford University · P30 · FY2025 · CA
Adult Leukemia Research Center
$4,395,431Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Adult Leukemia Research Center
$4,359,202Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$4,303,502Ali Naji · University Of Pennsylvania · U01 · FY2025 · AI
CD79B-TARGETING CAR T-CELL THERAPY FOR B-CELL LYMPHOMAS
$4,275,962The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2024 · Defense Health Agency
Stanford Cancer Institute
$4,223,653Steven E Artandi · Stanford University · P30 · FY2023 · CA
Stanford Cancer Institute
$4,223,653Steven E Artandi · Stanford University · P30 · FY2022 · CA
Stanford Cancer Institute
$4,223,653Steven E Artandi · Stanford University · P30 · FY2024 · CA
Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation
$4,216,302Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Enhancing anti-tumor immunity in head and neck neoplasms
$4,097,112Clint Allen · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$4,075,119Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
CCR Collaborative Bioinformatics Resource
$4,057,258Mariam Malik · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
T-Cell Receptor Gene Therapy for Human Cancers-Cures
$4,051,073James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA